Padma Ragahavan
-
Padma Raghavan appointed to a new role within the Office of the Chancellor
Padma Raghavan has been appointed to the newly created role of chancellor’s executive director for science and technology strategy, reporting directly to Chancellor Daniel Diermeier, beginning July 1. The move underscores Vanderbilt’s commitment to accelerating its impact in research and innovation at the national and global levels. Read MoreJun 25, 2025
-
Nashville Innovation Alliance awards first Tech Studio grant to improve emergency response
What if AI could fight fires? The first Nashville Tech Studio grant awarded by the Nashville Innovation Alliance fosters a collaboration between the Nashville Fire Department and Vanderbilt University that will analyze data to help allocate resources, determine optimal staffing levels and even predict future incidents. Read MoreMar 26, 2025
-
Inaugural Vanderbilt Convoy Conference showcases a buzzing entrepreneurial ecosystem
From networking to industry insights, the Convoy Conference highlighted how radical collaboration fuels Vanderbilt’s robust entrepreneurial ecosystem. Read MoreMar 20, 2025
-
Vanderbilt awarded up to $46M through ARPA-H to develop tools against alphaviruses
Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read MoreDec 2, 2024
-
Committee named in search for dean of College of Connected Computing
Provost and Vice Chancellor for Academic Affairs C. Cybele Raver has appointed a committee to conduct a national search for the first dean of Vanderbilt University’s new College of Connected Computing. The dean will report to the provost and to Bruce & Bridgitt Evans Dean of Engineering Krishnendu “Krish” Roy. Read MoreSep 23, 2024
-
Vanderbilt researchers, leaders participate in convening at King’s College Cambridge to discuss critical issues pertaining to post-quantum cryptography
Vanderbilt University, the University of Cambridge, King’s College Cambridge, the White House and the UK’s Government Communications Headquarters recently convened to showcase the power of academic collaboration on critical national security issues like the development of cryptographic algorithms that can hold up against quantum attacks. Read MoreAug 23, 2024
-
Vanderbilt, mayor’s office announce Nashville Innovation Alliance
The Nashville Innovation Alliance seeks to bring together public, private, civic and education institutions to collaborate on improving the region’s ecosystem for innovation and to research, develop and deploy technology and analytically based solutions to challenges facing Nashville and Davidson County. Read MoreJun 20, 2024
-
Vanderbilt researchers receive $2 million ARPA-H contract to improve software security in medical devices
Vanderbilt Department of Computer Science researchers Kevin Leach and James Weimer have won a $2 million award from the Advanced Research Projects Agency for Health to develop technology aimed at improving software security in medical devices like insulin pumps, pacemakers and stroke predictors. This is the first award Vanderbilt has received from ARPA-H, an agency within the National Institutes of Health with a mission to support “high-impact” solutions for pressing health care needs. Read MoreMay 20, 2024
-
Office of the Vice Provost for Research hosts ‘Nature Masterclass: Scientific Writing and Publishing’ Nov. 16
'Nature Masterclass: Scientific Writing and Publishing' will allow researchers to learn from the experts on what it takes to get your research published in top journals. All researchers whose work falls in relevant disciplines of STEM, the social sciences, medicine and biomedical sciences are invited to participate. Spots are limited; preference will be given to those registered by Oct. 22. Read MoreOct 18, 2023
-
Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment
Jacek Hawiger’s anti-inflammatory peptide therapy, licensed by Amytrx and now in clinical trials, has the potential to safely and effectively treat a multitude of inflammatory and metabolic diseases. Read MoreOct 27, 2020